Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Platelet-derived growth factor-BB (PDGF-BB) is a homodimeric growth factor composed of two B subunits. It plays a critical role in regulating cell growth, proliferation, chemotaxis, and angiogenesis. Primarily secreted by platelets, PDGF-BB binds to and activates PDGFRα and PDGFRβ receptor tyrosine kinases, initiating signaling pathways that are crucial for wound healing, tissue regeneration, and bone formation. However, it is also implicated in the pathology of cancer and fibrotic diseases due to its potent mitogenic and angiogenic properties. Recombinant human PDGF-BB is used clinically to enhance chronic ulcer healing.
Binds and activates PDGFRα and PDGFRβ receptor tyrosine kinases, leading to downstream signaling cascades that promote cell proliferation, migration, and angiogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Platelet-derived Growth Factor-BB (PDGF-BB).